What accounts for the variation in COVID-19 vaccine hesitancy in Eastern, Southern and Western Europe?

por Toshkov, Dimiter
Publicado 2023

Explaining the gender gap in COVID-19 vaccination attitudes

por Toshkov, Dimiter
Publicado 2023

Clinical presentation of monkeypox in patients with different HIV serostatus – two cases from Bulgaria: A case report

por Ivanov, Daniel Toshkov, Yancheva, Nina Stoyanova, Valkov, Trifon Kostadinov
Publicado 2023

Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis

por Antoch, Marina P, Toshkov, Ilia, Kuropatwinski, Karen K, Jackson, Marilyn
Publicado 2013

Information battleground: Conflict perceptions motivate the belief in and sharing of misinformation about the adversary

por Mazepus, Honorata, Osmudsen, Mathias, Bang-Petersen, Michael, Toshkov, Dimiter, Dimitrova, Antoaneta
Publicado 2023

Sertoli cells have a functional NALP3 inflammasome that can modulate autophagy and cytokine production

por Hayrabedyan, Soren, Todorova, Krassimira, Jabeen, Asma, Metodieva, Gergana, Toshkov, Stavri, Metodiev, Metodi V., Mincheff, Milcho, Fernández, Nelson
Publicado 2016

Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency

por Cheng, Le, Zhou, Zongxiang, Flesken-Nikitin, Andrea, Toshkov, Ilia A., Wang, Wei, Camps, Jordi, Ried, Thomas, Nikitin, Alexander Yu.
Publicado 2010

NPM1 Gene Type A Mutation in Bulgarian Adults with Acute Myeloid Leukemia: A Single-Institution Study

por Balatzenko, Gueorgui, Spassov, Branimir, Stoyanov, Nikolay, Ganeva, Penka, Dikov, Tihomit, Konstantinov, Spiro, Hrischev, Vasil, Romanova, Malina, Toshkov, Stavri, Guenova, Margarita
Publicado 2014

New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53(−/−) mice by delaying carcinogenesis

por Comas, Maria, Toshkov, Ilia, Kuropatwinski, Karen K., Chernova, Olga B., Polinsky, Alexander, Blagosklonny, Mikhail V., Gudkov, Andrei V., Antoch, Marina P.
Publicado 2012

Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer

por Burkhart, Catherine, Fleyshman, Daria, Kohrn, Rachael, Commane, Mairead, Garrigan, Jennifer, Kurbatov, Vadim, Toshkov, Ilya, Ramachandran, Rajesh, Martello, Laura, Gurova, Katerina V.
Publicado 2014

Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice

por Kojouharov, Bojidar M., Brackett, Craig M., Veith, Jean M., Johnson, Christopher P., Gitlin, Ilya I., Toshkov, Ilia A., Gleiberman, Anatoli S., Gudkov, Andrei V., Burdelya, Lyudmila G.
Publicado 2014

Physiological frailty index (PFI): quantitative in-life estimate of individual biological age in mice

por Antoch, Marina P., Wrobel, Michelle, Kuropatwinski, Karen K., Gitlin, Ilya, Leonova, Katerina I., Toshkov, Ilia, Gleiberman, Anatoli S., Hutson, Alan D., Chernova, Olga B., Gudkov, Andrei V.
Publicado 2017

Amplification of c-MYC and MLL Genes as a Marker of Clonal Cell Progression in Patients with Myeloid Malignancy and Trisomy of Chromosomes 8 or 11

por Angelova, S, Jordanova, M, Spassov, B, Shivarov, V, Simeonova, M, Christov, I, Angelova, P, Alexandrova, K, Stoimenov, A, Nikolova, V, Dimova, I, Ganeva, P, Tzvetkov, N, Hadjiev, E, Toshkov, S
Publicado 2011

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects

por Haderski, Gary J., Kandar, Bojidar M., Brackett, Craig M., Toshkov, Ilia M., Johnson, Christopher P., Paszkiewicz, Geraldine M., Natarajan, Venkatesh, Gleiberman, Anatoli S., Gudkov, Andrei V., Burdelya, Lyudmila G.
Publicado 2020

Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancer

por Antoch, Marina P., Wrobel, Michelle, Gillard, Bryan, Kuropatwinski, Karen K., Toshkov, Ilia, Gleiberman, Anatoli S., Karasik, Ellen, Moser, Michael T., Foster, Barbara A., Andrianova, Ekaterina L., Chernova, Olga V., Gudkov, Andrei V.
Publicado 2020

The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates

por Krivokrysenko, Vadim I., Toshkov, Ilia A., Gleiberman, Anatoli S., Krasnov, Peter, Shyshynova, Inna, Bespalov, Ivan, Maitra, Ratan K., Narizhneva, Natalya V., Singh, Vijay K., Whitnall, Mark H., Purmal, Andrei A., Shakhov, Alexander N., Gudkov, Andrei V., Feinstein, Elena
Publicado 2015

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications

por Mett, Vadim, Kurnasov, Oleg V., Bespalov, Ivan A., Molodtsov, Ivan, Brackett, Craig M., Burdelya, Lyudmila G., Purmal, Andrei A., Gleiberman, Anatoli S., Toshkov, Ilia A., Burkhart, Catherine A., Kogan, Yakov N., Andrianova, Ekaterina L., Gudkov, Andrei V., Osterman, Andrei L.
Publicado 2021

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy

por Mett, V, Komarova, E A, Greene, K, Bespalov, I, Brackett, C, Gillard, B, Gleiberman, A S, Toshkov, I A, Aygün-Sunar, S, Johnson, C, Karasik, E, Bapardekar-Nair, M, Kurnasov, O V, Osterman, A L, Stanhope-Baker, P S, Morrison, C, Moser, M T, Foster, B A, Gudkov, A V
Publicado 2018